Oral probiotic treatment of Lactobacillus rhamnosus Lcr35® prevents visceral hypersensitivity to a colonic inflammation and an acute psychological stress.

Y DarbakyB EvrardS PatrierJ FalentaS GarcinA TridonM DapoignyC SilberbergAdrien NivoliezL Diop

Published in: Journal of applied microbiology (2016)

Two formulas of Lcr35® probiotic strain show very encouraging results for the treatment of IBS patients. Further studies are needed to better understand the role and mechanisms of probiotics on the pathogenesis of IBS.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
oxidative stress
chronic kidney disease
liver failure
drug induced
type diabetes
intensive care unit
irritable bowel syndrome
combination therapy
depressive symptoms
respiratory failure
stress induced
hepatitis b virus
patient reported